Author

Lakshmi Sundar

M S Ramaiah University of Applied Sciences - Cited by 479 - Pharmacokinetics - Metabolism - Biomedical Analysis

Biography

Dr. Lakshmi Sundar  is currently working in India Diabetes Research Foundation, Chennai, Tamil Nadu, India. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Title
Cited by
Year
Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats
AK Gautam, B Bhargavan, AM Tyagi, K Srivastava, DK Yadav, M Kumar, ...The Journal of nutritional biochemistry 22 (4), 318-327, 2011201
86
2011
Medicarpin, a legume phytoalexin, stimulates osteoblast differentiation and promotes peak bone mass achievement in rats: evidence for estrogen receptor β-mediated osteogenic …
B Bhargavan, D Singh, AK Gautam, JS Mishra, A Kumar, A Goel, M Dixit, ...The Journal of nutritional biochemistry 23 (1), 27-38, 2012201
70
2012
A naturally occurring rare analog of quercetin promotes peak bone mass achievement and exerts anabolic effect on osteoporotic bone
JA Siddiqui, G Swarnkar, K Sharan, B Chakravarti, AK Gautam, P Rawat, ...Osteoporosis International 22, 3013-3027, 2011201
48
2011
Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect
K Sharan, JA Siddiqui, G Swarnkar, AM Tyagi, A Kumar, P Rawat, ...Menopause 17 (2), 3, 2010201
39
2010
QSAR study of 3-phenyl-5-acyloxymethyl-2H, 5H-furan-2-ones as antifungal agents: The dominant role of electronic parameter
P Vasanthanathan, M Lakshmi, MA Babu, AK Gupta, SG KaskhedikarChemical and pharmaceutical bulletin 54 (4), 583-587, 2006200
29
2006
Determination of metabolic profile of anti‐malarial trioxane CDRI 99/411 in rat liver microsomes using HPLC
S Mishra, L Manickavasagam, GK JainBiomedical Chromatography 26 (1), 115-122, 2012201
16
2012
Complementary role of herbal medicine and exercise in cardiovascular disease prevention and management: A review of evidence
S Kumar Veluswamy, A Samuel Babu, L Manickavasagam SundarCurrent pharmaceutical design 23 (8), 1253-1264, 2017201
16
2017
LC–MS/MS method for simultaneous analysis of cladrin and equol in rat plasma and its application in pharmacokinetics study of cladrin
L Manickavasagam, S Gupta, S Mishra, R Maurya, N Chattopadhyay, ...Medicinal Chemistry Research 20, 1566-1572, 2011201
8
2011
Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders
A Goel, A Kumar, S Chaurasia, D Singh, AK Gautam, R Pandey, R Trivedi, ...US Patent 8,686,028, 2014201
5
2014
QSAR study on pyridinone derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitor: a mixed approach
P Vasanthanathan, M Lakshmi, A Raghuram RaoMedicinal Chemistry 3 (3), 227-232, 2007200
4
2007
Classical QSAR Study on Chromene Derivatives as Lanosterol 14α-Demethylase Inhibitor: A Non Azole Antifungal Target
Classical QSAR Study on Chromene Derivatives as Lanosterol 1α-Demethylase Inhibitor: A Non Azole Antifungal TargetP Vasanthanathan, M Lakshmi, MA Babu, SG KaskhedikarMedicinal Chemistry 2 (), 363-367, 2006200
4
2006
3
2014
Influence of Thermodynamic Parameter in Lanosterol 14α-Demethylase Inhibitory Activity as Antifungal Agents: A QSAR Approach
P Vasanthanathan, M Lakshmi, MA Babu, SG KaskhedikarBiological and Pharmaceutical Bulletin 29 (6), 1262-1266, 2006200
3
2006
Determination of 3‐hydroxy pterocarpan, a novel osteogenic compound in rat plasma by liquid chromatography–tandem mass spectrometry: application to pharmacokinetics study
L Manickavasagam, S Gupta, S Mishra, A Kumar, A Raghuvanshi, A Goel, ...Biomedical chromatography 5 (7), 843-850, 01101
2
2011
Novel flavonol compounds, compositions thereof and method for treating bone disorders
R Maurya, P Rawat, K Sharan, JA Siddiqui, G Swarnkar, G Mishra, ...US Patent App. 4/59,23, 20420
1
2014